drugset
drugset / Trial / NCT01495377

Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration

NCT01495377 ↗

Phase 4 Completed 25 enrolled Region Örebro County
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine weather remifentanil induced swallowing difficulties increase risk for pulmonary aspiration.

Timeline

Start
2012-01
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Remifentanil Small molecule 3 ng/ml Other
Background Technetium Diagnostic / imaging agent 37 mbq Other
Background Technetium Diagnostic / imaging agent 40 mbq Other

Indications

No indication recorded.